Articles related to MEDICAL UNIVERSITY PRESS

Explore the transformative potential of antibody-drug conjugates (ADCs) in cancer therapy, offering targeted treatments with reduced side effects. Recent approvals and ongoing trials signify a significant shift towards precision medicine in oncology.

Explore the potential of IS-002, an imaging agent that offers a new dimension in intraoperative prostate cancer detection, promising a more targeted approach to surgical intervention and patient management.

In a significant advance for pediatric diabetes care, the introduction of the AI-based IDx-DR has doubled screening rates for diabetic retinopathy, underscoring the potential of technology to democratize healthcare access and eliminate racial bias in diagnostic processes.

Leveraging artificial intelligence, the CathEF algorithm offers a groundbreaking method to assess heart function directly from angiogram videos, potentially reducing the need for invasive diagnostics and enhancing patient care strategies.

Johns Hopkins’ cardiac surgery team’s strategic expansion brings together globally recognized experts, enhancing our capabilities in treating complex heart conditions and advancing research in heart and lung transplantation.

In the landmark KEYNOTE-564 trial, pembrolizumab has emerged as a pivotal advancement in kidney cancer treatment, offering hope by significantly prolonging survival in patients with high-risk ccRCC post-nephrectomy.